In contrast, among Ethiopian patients, anti-TB cotreatment increased the mean plasma efavirenz concentration, particularly among carriers of CYP2B6*6 allele both at week 4 (p = 0.003) and at week 16 (p = 0.035). This evidence concerns the gene CYP2B6 and tuberculosis.